Mathai Mammen

2008

In 2008, Mathai Mammen earned a total compensation of $1.8M as Senior Vice President, Research Early Clinical Development at Innoviva.

Compensation breakdown

Bonus$21,600
Non-Equity Incentive Plan$292,938
Option Awards$979,580
Salary$299,813
Stock Awards$217,800
Total$1,811,731

Mammen received $979.6K in option awards, accounting for 54% of the total pay in 2008.

Mammen also received $21.6K in bonus, $292.9K in non-equity incentive plan, $299.8K in salary and $217.8K in stock awards.

Rankings

In 2008, Mathai Mammen's compensation ranked 2,704th out of 9,135 executives tracked by ExecPay. In other words, Mammen earned more than 70.4% of executives.

ClassificationRankingPercentile
All
2,704
out of 9,135
70th
Division
Manufacturing
967
out of 3,436
72nd
Major group
Chemicals And Allied Products
168
out of 815
79th
Industry group
Drugs
99
out of 597
83rd
Industry
Pharmaceutical Preparations
76
out of 408
81st
Source: SEC filing on March 16, 2011.

Mammen's colleagues

We found five more compensation records of executives who worked with Mathai Mammen at Innoviva in 2008.

2008

Rick Winningham

Innoviva

Chief Executive Officer

2008

Michael Aguiar

Innoviva

Chief Financial Officer

2008

Leonard Blum

Innoviva

Senior Vice President and Chief Commercial Officer

2008

Arthur Campbell

Innoviva

Former Senior Vice President, Technical Operations

2008

Bradford Shafer

Innoviva

General Counsel

In-depth

You may also like